This activity will provide learners with an overview of clinical considerations in adults with IDD and improve communication skills and practices that can better guide treatment choices to address the specific needs of these individuals. Learners will take a closer look at existing bias, stigma and discrimination toward these individuals and learn strategies to address these issues in practice. Lastly, the value of improved interprofessional team collaboration between health care professionals (HCPs), caregivers and direct support professionals will be discussed.

This activity will examine how the multiple aspects of digital health can be best utilized by health care team members to ensure continuity of the patient’s health care journey, meet care plan goals, improve patient outcomes and optimize team communication practices. The ability of virtual health care practices to enable team members to fulfill their roles in clinical decision-making and care plan implementation will be discussed. Important legal, regulatory and reimbursement considerations that pertain to digital practice integration within the health care team will be highlighted.

This session examines the cost of development and growth of these pharmaceuticals and details the specific role that specialty pharmacy plays in making these products accessible. The high costs of therapies and patient and medication management are also discussed along with the role and value of drug benefit programs.

This activity will highlight new updates in our understanding of how diabesity develops and describe the negative physiologic effects of this disease on multiple body systems, notably the cardiovascular and renal systems. Optimal treatments for diabesity will be identified, along with an overview of the health burden of diabesity related to long-term complications and reduced function, quality of life and life expectancy.